Clinical Study
Serum β-Catenin Levels Associated with the Ratio of RANKL/OPG in Patients with Postmenopausal Osteoporosis
Table 1
The characteristics and laboratory data of patients and controls.
| | PMOP group | Control group | |
| Number | 480 | 170 | | Age (years) | | | 0.813 | Weight (kg) | | | 0.823 | Height (m) | | | 0.277 | BMI (kg/m2) | | | 0.190 | BMD (g/m2) | | | <0.001 | T-score | | | <0.001 | Estradiol (pmol/mL) | | | 0.157 | N-MID-OT (ng/mL) | | | 0.564 | 25(OH)D (ng/mL) | | | 0.893 | CTX (ng/mL) | | | <0.001 | PINP (ng/mL) | | | 0.005 | -catenin (pg/mL) | | | <0.001 | Sclerostin (pmol/L) | | | <0.001 | OPG (pg/mL) | | | 0.679 | RANKL (pmol/L) | | | <0.001 | Ratio of RANKL/OPG | | | <0.001 |
|
|
Data for continuous variables are presented as mean ± SD.
|